Jenny Shan

Statistics

Publications

Citations

1.8K

H-Index

Active since

2002

Affiliations

The University of Texas MD Anderson Cancer Center(Current)

The University of Texas Health Science Center at Houston

Jenny Shan is an author at The University of Texas MD Anderson Cancer Center specializing in medicine, chronic myeloid leukemia therapy, and oncology.

Publications per year

2002–2012

Publications

Improved survival in chronic myeloid leukemia since the introduction of imatinib therapy: a single-institution historical experience

Hagop M. Kantarjian, Susan O’Brien, Elias Jabbour et al. · Blood · 2012 · 338 citations · Full text

Medicine, Hematology, Oncology +5

Outcome of patients with myelodysplastic syndrome after failure of decitabine therapy

Elias Jabbour, Guillermo Garcia‐Manero, Nicolas Batty et al. · Cancer · 2010 · 278 citations · Full text

Medicine, Oncology, Pharmacotherapy +12

Molecular Responses in Patients with Chronic Myelogenous Leukemia in Chronic Phase Treated with Imatinib Mesylate

Jörge E. Cortes, Moshe Talpaz, Susan O’Brien et al. · Clinical Cancer Research · 2005 · 265 citations

Medicine, Hematology, Oncology +8

Imatinib mesylate dose escalation is associated with durable responses in patients with chronic myeloid leukemia after cytogenetic failure on standard-dose imatinib therapy

Elias Jabbour, Hagop M. Kantarjian, Dan Jones et al. · Blood · 2008 · 154 citations · Full text

Medicine, Oncology, Pharmacology +9

The achievement of an early complete cytogenetic response is a major determinant for outcome in patients with early chronic phase chronic myeloid leukemia treated with tyrosine kinase inhibitors

Elias Jabbour, Hagop M. Kantarjian, Susan O’Brien et al. · Blood · 2011 · 151 citations · Full text

Medicine, Hematology, Oncology +13

1–5 of 18